Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FASN | P49327 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 6/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | F7 | P08709 | 1/20 | 0.39 |
| ▸ | F3 | P13726 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 2/20 | 0.36 |
| ▸ | CNR2 | P34972 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21483880 | 1.00 | TSHR (0.52) | TSHRALDH1A1TDP1FASNFAAH | |
| SCHEMBL21483907 | 1.00 | TSHR (0.52) | TSHRALDH1A1TDP1FASNFAAH | |
| SCHEMBL21483914 | 1.00 | TSHR (0.52) | TSHRALDH1A1TDP1FASNFAAH | |
| SCHEMBL21483972 | 0.98 | TSHR (0.55) | TSHRALDH1A1TDP1FASNFAAH | |
| SCHEMBL21483960 | 0.98 | TSHR (0.55) | TSHRALDH1A1TDP1FASNFAAH | |
| SCHEMBL21483885 | 0.98 | TSHR (0.55) | TSHRALDH1A1TDP1FASNFAAH | |
| SCHEMBL21483878 | 0.98 | TSHR (0.55) | TSHRALDH1A1TDP1FASNFAAH | |
| SCHEMBL21483966 | 0.98 | TSHR (0.55) | TSHRALDH1A1TDP1FASNFAAH | |
| SCHEMBL21491093 | 0.98 | TSHR (0.55) | TSHRALDH1A1TDP1FASNFAAH | |
| SCHEMBL21483910 | 0.98 | TSHR (0.55) | TSHRALDH1A1TDP1FASNFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110386855-B | 1-halodiene and process for preparing it and (9E, 111Z) -9, 11-hexadecadienylacetate | 信越化学工业株式会社 | 2023-03-28 | — | — | CN | disclosed |
| US-10737999-B2 | 1-haloalkadiene and a process for preparing the same and a process for preparing (9e, 11z)-9,11-hexadecadienyl acetate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-08-11 | — | — | US | disclosed |
| US-20190322614-A1 | 1-HALOALKADIENE AND A PROCESS FOR PREPARING THE SAME AND A PROCESS FOR PREPARING (9e, 11z)-9,11-HEXADECADIENYL ACETATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-10-24 | — | — | US | disclosed |
| EP-3556742-A1 | 1-HALOALKADIENE AND PROCESS FOR PREPARING THE SAME AND A PROCESS FOR PREPARING (9E,11Z)-9,11-HEXADECADIENYL ACETATE | Shin-Etsu Chemical Co., Ltd. (JP) | 2019-10-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190322614-A1 | 1-HALOALKADIENE AND A PROCESS FOR PREPARING THE SAME AND A PROCESS FOR PREPARING (9e, 11z)-9,11-HEXADECADIENYL ACETATE | CYP8B1, HDHD5, HACL2 | TSHR 2265/4885ALDH1A1 391/4885TDP1 3908/4885 |
| US-10737999-B2 | 1-haloalkadiene and a process for preparing the same and a process for preparing (9e, 11z)-9,11-hexadecadienyl acetate | CYP8B1, HDHD5, HACL2 | TSHR 2265/4885ALDH1A1 391/4885TDP1 3908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.